Infusion Pump Market Size, Outlook, Analysis, Research, Review 2024–2032
Beginning at USD 9.02 billion in 2020, the infusion pump market is projected to increase from USD 9.67 billion in 2021 to USD 15.81 billion in 2028, exhibiting a CAGR of 7.3% during the 2021–2028 period.
In a recent study, Fortune Business Insights presents the nitty-gritty of the global Infusion Pump Market considering 2024–2032 as the stipulated timeframe. The business report highlights the drivers, restraints, opportunities and trends affecting market growth. Further, all the market shares associated with the market as well as the segments are expressed in terms of value and volume.
Request a Free Sample PDF Brochure of Infusion Pump Market: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/102554
The Infusion Pump Market study outlines the key regions of North America, Latin America, Europe, East Asia, Japan along with the countries contributing the most in the respective regions. The report presents detailed insights about each market player, including SWOT analysis, main market information, market share, revenue, pricing and gross margin. Prominent players covered in this research are
- Medtronic (Ireland)
- Becton Dickinson and Company (U.S.)
- Baxter (U.S.)
- Insulet Corporation (U.S.)
- ICU Medical, Inc. (U.S.)
- B. Braun Melsungen AG (Germany)
- Smiths Medical (Smiths Group plc.) (U.S.)
- Fresenius Kabi AG (Germany)
- Terumo Corporation (Japan)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
Market Dynamics
Infusion pumps provide important advantages over the manual delivery of fluids like the ability to administer the fluids in a very small dosage and at accurate programmed rates. In many cases like cancer and diabetic conditions, these pumps are used to deliver the medication to maintain drug level in the bloodstream at a steady state. According to the World Health Organization (WHO), in 2018, cancer was estimated to be the second most prominent cause of death globally and is responsible for about 9.6 million deaths. Cancer patients require chemotherapy which is to be delivered to the patients in a continuous manner which can be achieved by using the pump. Moreover, according to the Centers for Disease Control and Prevention (CDC), in 2020, the prevalence of diabetes was estimated to be around 463 million cases worldwide and in the U.S., 34.2 million adults have diabetes which is 10.5% of the total population. The insulin pumps are increasingly being preferred in the management of type 1 diabetes. These patients necessitate user friendly self-controlled pumps to achieve continuous medication delivery. Together, these factors are surging the infusion pump market growth across all regions.
The insights for each vendor consist of:
- Company profile
- SWOT analysis
- Main market information
- Market share
- Revenue, pricing and gross margin
Speak to Our Analyst: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/102554
Crucial insights in the Infusion Pump Market research:
- Underlying macro- and microeconomic factors impacting the growth of the Infusion Pump Market.
- Basic overview of Infusion Pump Market, including market definition, classification, and applications.
- Scrutinization of each Infusion Pump Market player based on mergers & acquisitions, R&D projects, and product launches.
- Adoption trend of Infusion Pump Market across various industries.
- Important regions and countries offering lucrative opportunities to Infusion Pump Market stakeholders.
Segmentation Analysis:
By Type
- Volumetric Pumps
- Syringe Pumps
- Elastomeric Pumps
- Insulin Pumps
- Enteral Pumps
- Implantable Pumps
Patient Control Analgesia (PCA) Pumps
By Application
- Diabetes
- Oncology
- Pain Management
- Others
Important regions covered in the Infusion Pump Market report include:
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Order a copy of this research report at — https://www.fortunebusinessinsights.com/checkout-page/102554
RELATED REPORTS:
Intravenous Immunoglobulins Market
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
Email: sales@fortunebusinessinsights.com
Phone: US: +1 424 253 0390, UK: +44 2071 939123, APAC: +91 74